Tibor Keler's most recent trade in Celldex Therapeutics Inc. was a trade of 93,000 Incentive Stock Option (right to buy) done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Celldex Therapeutics Inc. | Tibor Keler | EXECUTIVE VP & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 93,000 | 93,000 | - | - | Incentive Stock Option (right to buy) | |
| Celldex Therapeutics Inc. | Tibor Keler | EXECUTIVE VP & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 93,000 | 93,000 | - | - | Incentive Stock Option (right to buy) | |
| Celldex Therapeutics Inc. | Tibor Keler | EXECUTIVE VP & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 92,000 | 92,000 | - | - | Incentive Stock Option (right to buy) | |
| Celldex Therapeutics Inc. | Tibor Keler | EXECUTIVE VP & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 91,000 | 91,000 | - | - | Incentive Stock Option (right to buy) | |
| Celldex Therapeutics Inc. | Tibor Keler | Executive VP & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 91,000 | 91,000 | - | - | Incentive Stock Option (right to buy) |